Get the Daily Brief
Latest Biotech News
Hybrid Cooling Technology Offers Energy Efficient Solution for Data Centers
UC San Diego engineers developed a novel evaporative cooling technology employing a low-cost fiber membrane with interconnected pores that passively removes heat from electronics through...
Sarepta Pauses Duchenne Gene Therapy After Second Patient Death
Sarepta Therapeutics halted delivery of its gene therapy Elevidys for Duchenne muscular dystrophy patients who are non-ambulatory after the second fatal liver failure case. The company is working...
Anne Wojcicki’s Nonprofit Tops 23andMe Asset Auction
Anne Wojcicki’s nonprofit TTAM Research Institute secured 23andMe’s assets for $305 million, surpassing Regeneron’s bid in bankruptcy court proceedings. The acquisition includes commitments to...
ADC Therapeutics Cuts UK Site and 30% Workforce After Trial Failures
After discontinuing its only clinical-stage candidate and several preclinical solid tumor programs, ADC Therapeutics announced the closure of its UK research site and 30% workforce reduction. This...
Sarepta Halts Duchenne Gene Therapy Shipments After Second Death
Sarepta Therapeutics has ceased shipments of its Duchenne muscular dystrophy gene therapy Elevidys for non-ambulatory patients following a second fatality due to acute liver failure. Both deaths...
New Biomarkers and Mechanisms in Parkinson’s Disease Research
Recent studies published in npj Parkinson’s Disease and others reveal advancements in understanding Parkinson’s disease pathology, including the role of cutaneous nerve fibers and brain...
FDA Approves Checkpoint Inhibitor for Head and Neck Cancer
The FDA has approved pembrolizumab for patients with resectable locally advanced head and neck squamous cell carcinoma expressing PD-L1, based on the phase 3 KEYNOTE-689 trial. The regimen of...
Rapid Vascular Organoid Generation Advances Regenerative Medicine
Researchers from Boston Children’s Hospital and collaborators have developed a method accelerating vascular organoid formation from human iPSCs by dual transcription factor activation. This...
Anne Wojcicki’s Nonprofit Wins 23andMe Bidding War
Anne Wojcicki, co-founder and former CEO of 23andMe, through her nonprofit TTAM Research Institute, outbid Regeneron with a $305 million offer for the genetic testing company’s assets. The...
Innovations in Multiomics and Proteomics Technology Integration
The multiomics field is evolving as companies prioritize combining gene sequencing with proteomics. Collaborations like those between Ultima Genomics and Olink, and Illumina with SomaLogic,...
Quantum Simulation Breakthrough Illuminates Particle 'String Breaking'
Two international teams using quantum computers—one at QuEra Computing and another at Google Quantum AI Lab—have successfully simulated the real-time phenomenon of particle string breaking, where...
New Cooling Technology Promises Energy Efficiency for Data Centers
Engineers at UC San Diego have developed a novel evaporative cooling device using fiber membranes that passively dissipate heat from electronics. This system, described in Joule, could markedly...
Breakthrough in Cancer CAR-T Therapy Shows Promising Clinical Results
Johnson and Johnson report encouraging phase 1b trial data for their dual-targeting CAR-T therapy in relapsed/refractory large B-cell lymphoma. Among patients with one prior treatment, a 100%...
Advances in AI-Driven Spatial Transcriptomics Resource Released
Northwestern University released SOAR, an expansive spatial transcriptomics platform aggregating over 3,400 samples across species and tissue types to enable comprehensive cell-cell interaction...
Sarepta Pauses Duchenne Gene Therapy After Second Patient Death
Sarepta Therapeutics halted shipping its Duchenne muscular dystrophy gene therapy, Elevidys, for non-ambulatory patients after a second death due to acute liver failure. The company is working on...
J&J Reports 100% Response Rate in Early Dual-Antigen CAR-T Trial
Johnson & Johnson revealed data from a phase 1b trial showing 100% objective response in relapsed/refractory large B-cell lymphoma patients with one prior therapy following treatment with a dual...
Sarepta Pauses Duchenne Gene Therapy After Second Patient Death
Sarepta Therapeutics halted shipping its Duchenne muscular dystrophy gene therapy, Elevidys, for non-ambulatory patients after a second death due to acute liver failure. The company is working on...
Gene Therapy Safety Hit: Sarepta Pauses Duchenne Drug
Sarepta Therapeutics has suspended shipments of its Duchenne muscular dystrophy gene therapy, Elevidys, for non-ambulatory patients following a second death linked to acute liver failure. Both...
Parkinson’s Diagnostics: Nerve Fiber and Perivascular Biomarkers
Recent studies highlight novel Parkinson's disease biomarkers derived from peripheral and brain vasculature. One cohort study published in npj Parkinson’s Disease revealed pathological changes in...
Rapid Vascular Organoid Formation via Transcription Factor Control
A new method enables swift generation of functional vascular organoids from human stem cells by simultaneous activation of endothelial and mural lineage transcription factors. Published in Cell...